Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors
Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors – Licensing opportunity (PDF)
Explore other Stories:
Biobanks crucial for novel diagnostics or therapeutics
Biobanks contain valuable information on the donor of the sample. Access to these collections can be crucial for companies developing novel diagnostics or therapeutics.
Story of Maaike van Rest (VU Amsterdam)
How to make an impact with your research and what does it take to go from idea to product or service. Watch the video of Maaike van Rest. Maaike explains what has helped her to bring an idea to the market in the shape of a product.
Dr. Alexander Kostenko’s tips for creating a start-up
What are the first steps when beginning a start-up? IXA sat down with postdoctoral researcher and entrepreneur Alexander Kostenko to obtain advice for starting academic entrepreneurs. Starting a company is “really hard,” explains Alexander Kostenko with a smile. Alexander found his start-up Photosynthetic in 2019 so he could build high-end 3D printers that make micron-sized objects […]